These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 21344316)
21. No gain, no pain: NaV1.7 as an analgesic target. King GF; Vetter I ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714 [TBL] [Abstract][Full Text] [Related]
22. Multiple mechanisms have been tested in pain--how can we improve the chances of success? Hayes AG; Arendt-Nielsen L; Tate S Curr Opin Pharmacol; 2014 Feb; 14():11-7. PubMed ID: 24565006 [TBL] [Abstract][Full Text] [Related]
23. Replacement of current opioid drugs focusing on MOR-related strategies. Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137 [TBL] [Abstract][Full Text] [Related]
24. Human pharmacological approaches to TRP-ion-channel-based analgesic drug development. Weyer-Menkhoff I; Lötsch J Drug Discov Today; 2018 Dec; 23(12):2003-2012. PubMed ID: 29969684 [TBL] [Abstract][Full Text] [Related]
25. [Pain and analgesia : Mutations of voltage-gated sodium channels]. Eberhardt MJ; Leffler A Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262 [TBL] [Abstract][Full Text] [Related]
26. Computational functional genomics-based approaches in analgesic drug discovery and repurposing. Lippmann C; Kringel D; Ultsch A; Lötsch J Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109 [TBL] [Abstract][Full Text] [Related]
29. Targeting N-type and T-type calcium channels for the treatment of pain. McGivern JG Drug Discov Today; 2006 Mar; 11(5-6):245-53. PubMed ID: 16580601 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics of opioids and perioperative pain management. Sadhasivam S; Chidambaran V Pharmacogenomics; 2012 Nov; 13(15):1719-40. PubMed ID: 23171337 [TBL] [Abstract][Full Text] [Related]
31. Molecules to selectively target receptors for treatment of pain and neurogenic inflammation. Andreev YA; Vassilevski AA; Kozlov SA Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):35-45. PubMed ID: 22185455 [TBL] [Abstract][Full Text] [Related]
32. Neuroimaging as a tool to investigate how cognitive factors influence analgesic drug outcomes. Bingel U; Tracey I; Wiech K Neurosci Lett; 2012 Jun; 520(2):149-55. PubMed ID: 22561551 [TBL] [Abstract][Full Text] [Related]
33. Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain. Merighi A Expert Opin Ther Targets; 2016; 20(2):193-208. PubMed ID: 26863504 [TBL] [Abstract][Full Text] [Related]
34. [MODERN VIEWS ON THE PHARMACOGENETICS OF PAIN.]. Makharin OA; Zhenilo VM; Patyuchenko OY Anesteziol Reanimatol; 2017 Sep; 61():219-223. PubMed ID: 29465208 [TBL] [Abstract][Full Text] [Related]
35. Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Jarvis MF Expert Opin Ther Targets; 2003 Aug; 7(4):513-22. PubMed ID: 12885270 [TBL] [Abstract][Full Text] [Related]
36. A Human TRPA1-Specific Pain Model. Heber S; Gold-Binder M; Ciotu CI; Witek M; Ninidze N; Kress HG; Fischer MJM J Neurosci; 2019 May; 39(20):3845-3855. PubMed ID: 30862667 [TBL] [Abstract][Full Text] [Related]
37. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Taneja A; Della Pasqua O; Danhof M Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907 [TBL] [Abstract][Full Text] [Related]
38. An observational study of the impact of genetic testing for pain perception in the clinical management of chronic non-cancer pain. Sharma M; Kantorovich S; Lee C; Anand N; Blanchard J; Fung ET; Meshkin B; Brenton A; Richeimer S J Psychiatr Res; 2017 Jun; 89():65-72. PubMed ID: 28182962 [TBL] [Abstract][Full Text] [Related]
39. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain. Rahman W; Dickenson AH Curr Opin Support Palliat Care; 2015 Jun; 9(2):124-30. PubMed ID: 25730180 [TBL] [Abstract][Full Text] [Related]